The Positive Effect of Sacubitril/Valsartan Therapy on QRS Width and QTC Interval on Electrocardiogram in Heart Failure Patients With Reduced Ejection Fraction
by Prateek Chopra | June 1, 2026 | Cardiology Conferences | ESC-HF 2026 Sacubitril/valsartan (S/V) therapy has been shown to reduce hospitalizations, improve echocardiographic parameters, and lower mortality in patients with heart failure with reduced ejection fraction (HFrEF; EF <40%). S/V therapy has also been associated with reductions in ventricular tachycardia episodes and premature ventricular contractions. However, the precise mechanism underlying […]